OS-063 Digital risk stratification management platform improves the early diagnosis and surveillance of liver cancer in china: a realworld study in Zhuhai people’s hospital
Qing Yang(Guangzhou University of Chinese Medicine), Yong Li(Sutherland Hospital), Xiaolei Zhou(Guangxi Medicinal Botanical Garden), Manhua Zhong, Chaowen Pu(Fuling Center Hospital of Chongqing), Xiaofeng Wang(Cleveland Clinic Lerner College of Medicine), Bing Liu(Central South University), Yanhong Chen(Xuzhou Central Hospital), Linfang Li, Kee Jit Thye, Yusen Wu
Cited by 0
Related Papers
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling
|Molecular Cancer|2017|257
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218